Novo Nordisk ADR (NYSE: NVO)’s stock price has dropped by -2.52 in relation to previous closing price of 86.26. Nevertheless, the company has seen a
Novo Nordisk ADR (NYSE: NVO) has a higher price-to-earnings ratio of 27.82x compared to its average ratio. NVO has 36-month beta value of 0.45. Analysts
Novo Nordisk ADR (NYSE: NVO)’s stock price has gone decline by -0.32 in comparison to its previous close of 87.65, however, the company has experienced
The stock of Novo Nordisk ADR (NVO) has gone down by -20.52% for the week, with a -19.26% drop in the past month and a
Novo Nordisk ADR (NYSE: NVO)’s stock price has plunge by -1.53relation to previous closing price of 108.61. Nevertheless, the company has seen a -3.45% plunge
© 2024, Powered by Smart TechOne
